Healing of Corneal Incision After Cataract Surgery in Diabetic Patients
Corneal Incision Healing and Its Influencing Factors After Cataract Phacoemulsification in Diabetic Patients -- Based on Anterior Segment Optical Coherence Tomography
1 other identifier
observational
110
1 country
1
Brief Summary
The objective of this observational study was to understand the healing of corneal incision after cataract surgery in diabetic patients and its influencing factors. The main questions it aims to answer are: Is corneal incision healing worse in diabetic patients after cataract surgery than in non-diabetic patients? What are the factors affecting corneal incision healing after cataract surgery in diabetic patients? The results of anterior segment optical coherence tomography before and after cataract surgery in cataract patients with or without diabetes will be collected and analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2025
CompletedFirst Submitted
Initial submission to the registry
July 14, 2025
CompletedFirst Posted
Study publicly available on registry
July 22, 2025
CompletedJuly 22, 2025
July 1, 2025
9 months
July 14, 2025
July 14, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
volume of half cornea with surgical incision
Before surgery; 1 week after surgery; 1 month after surgery
Defect of corneal incision healing
Opening of internal orifice; Endothelial dislocation; Descemet's membrane detachment
1 week after surgery; 1 month after surgery
Study Arms (2)
Diabetes group
Control group
Eligibility Criteria
Patients who were initially diagnosed with cataract and treated with phacoemulsification and intraocular lens implantation at Zhongnan Hospital of Wuhan University from April 1, 2024 to December 31, 2024.
You may qualify if:
- Patients who experience blurred vision and painless visual acuity decline, and are diagnosed with cataract (with or without diabetes) through reliable intraocular pressure, visual acuity and slit lamp examinations, and for whom phacoemulsification of cataract can be considered.
You may not qualify if:
- Use multiple eye drops before surgery.
- Complicated by other eye diseases that affect corneal healing, such as keratitis, uveitis, glaucoma, etc.
- Moderate to severe dry eye.
- History of eye surgery.
- Moderate to severe dry eye.
- Grade 5 nuclear cataract.
- Severe systemic diseases (such as chronic renal failure requiring dialysis, severe neurological diseases, immune diseases), pregnancy or lactation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, 430071, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 14, 2025
First Posted
July 22, 2025
Study Start
April 1, 2024
Primary Completion
December 31, 2024
Study Completion
January 15, 2025
Last Updated
July 22, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share